Kirsti Näntö-Salonen

- Docent,
Faculty of Medicine (University of Turku)

kinasa@utu.fi

1 of 2

DNA methylation differences within INS, PTPN22 and IL2RA promoters in lymphocyte subsets in children with type 1 diabetes and controls2023
- AutoimmunityMetabolism
Pahkuri Sirpa, Ekman Ilse, Vandamme Céline, Näntö-Salonen Kirsti, Toppari Jorma, Veijola Riitta, Knip Mikael, Kinnunen Tuure, Ilonen Jorma, Lempainen Johanna
(2023)
- Frontiers in ImmunologyJIMD Reports
Schroderus Anna-Mari, Poorbaugh Josh, McElyea Samantha, Beasley Stephanie, Zhang Lin, Näntö-Salonen Kirsti, Rintamäki Reeta, Pihlajamäki Jussi, Knip Mikael, Veijola Riitta, Toppari Jorma, Ilonen Jorma, Benschop Robert J., Kinnunen Tuure
Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes (2020)
- Diabetologia
Ahmad M. Gazali, Anna-Mari Schroderus, Kirsti Näntö-Salonen, Reeta Rintamäki, Jussi Pihlajamäki, Mikael Knip, Riitta Veijola, Jorma Toppari, Jorma Ilonen, Tuure Kinnunen
Circulating CXCR5−PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes (2019)
- Diabetologia
Ilse Ekman, Emmi-Leena Ihantola, Tyyne Viisanen, Deepak A. Rao, Kirsti Näntö-Salonen, Mikael Knip, Riitta Veijola, Jorma Toppari, Jorma Ilonen, Tuure Kinnunen
FOXP3+Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children (2019)
- Frontiers in Immunology
Tyyne Viisanen, Ahmad M. Gazali, Emmi-Leena Ihantola, Ilse Ekman, Kirsti Näntö-Salonen, Riitta Veijola, Jorma Toppari, Mikael Knip, Jorma Ilonen, Tuure Kinnunen
The psychosocial self-efficacy in adolescents with type 1 diabetes (2019)
- Nursing Open
Anne Survonen, Sanna Salanterä, Kirsi Näntö-Salonen, Arun K. Sigurdardottir, Riitta Suhonen
Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment (2018)
- Haemophilia
Zuurveld M., Kopatz W., Brinkman H., Meijers J., Lassila R., Pitkänen H., Kärki M., Niinikoski H., Tanner L., Näntö-Salonen K., Pikta M.
Effector T Cell Resistance to Suppression and STAT3 Signaling during the Development of Human Type 1 Diabetes (2018)
- Journal of Immunology
Emmi-Leena Ihantola, Tyyne Viisanen, Ahmad M. Gazali, Kirsti Näntö-Salonen, Auni Juutilainen, Leena Moilanen, Reeta Rintamäki, Jussi Pihlajamäki, Riitta Veijola, Jorma Toppari, Mikael Knip, Jorma Ilonen, Tuure Kinnunen
Synnynnäisen hypotyreoosin seulonta vastasyntyneiltä kuiva- ja napaverinäytteistä (2018)
- Lääkärilehti
Anna Linko-Parvinen, Annika Kouki, Johanna Uitto, Riikka Kurkijärvi, Britt-Marie Loo, Tiina Heinonen, Kirsti Näntö-Salonen, Harri Niinikoski, Ilkka Mononen
Vastasyntyneiden aineenvaihduntasairauksien seulonta (2018)
- Duodecim
Risto Lapatto, Harri Niinikoski, Kirsti Näntö-Salonen, Ilkka Mononen
Circulating CXCR5(+)PD-1(+)ICOS(+) Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies (2017)
- Diabetes
Viisanen T, Ihantola EL, Nanto-Salonen K, Hyoty H, Nurminen N, Selvenius J, Juutilainen A, Moilanen L, Pihlajamaki J, Veijola R, Toppari J, Knip M, Ilonen J, Kinnunen T
Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes A Randomized Clinical Trial (2017)
- JAMA: Journal of the American Medical Association
Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group
Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance (2017)
- JIMD Reports
Laura M. Tanner, Johanna Kurko, Maaria Tringham, Heikki Aho, Juha Mykkänen, Kirsti Näntö-Salonen, Harri Niinikoski, Heikki Lukkarinen
A Comparison of Rule-based Analysis with Regression Methods in Understanding the Risk Factors for Study Withdrawal in a Pediatric Study (2016)
- Scientific Reports
Haghighi M., Johnson S., Qian X., Lynch K., Vehik K., Huang S.; The TEDDY Study Group
Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI) (2016)
Kurko J, Tringham M, Tanner L, Nanto-Salonen K, Vaha-Makila M, Nygren H, Poho P, Lietzen N, Mattila I, Olkku A, Hyotylainen T, Oresic M, Simell O, Niinikoski H, Mykkanen J
Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI (2016)
Kärki M, Näntö-Salonen K, Niinikoski H, Tanner LM.
A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY (2015)
- BMC Pediatrics
Lonnrot M, Lynch K, Larsson HE, Lernmark A, Rewers M, Hagopian W, She JX, Simell O, Ziegler AG, Akolkar B, Krischer J, Hyoty H; and The TEDDY study group
Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport (2015)
- Molecular Immunology
Kurko J, Vähä-Mäkilä M, Tringham M, Tanner L, Paavanen-Huhtala S, Saarinen M, Näntö-Salonen K, Simell O, Niinikoski H, Mykkänen J
Early Childhood Gut Microbiomes Show Strong Geographic Differences Among Subjects at High Risk for Type 1 Diabetes (2015)
- Diabetes Care
Kemppainen KM, Ardissone AN, Davis-Richardson AG, Fagen JR, Gano KA, Leon-Novelo LG, Vehik K, Casella G, Simell O, Ziegler AG, Rewers MJ, Lernmark A, Hagopian W, She JX, Krischer JP, Akolkar B, Schatz DA, Atkinson MA, Triplett EW; the TEDDY Study Group
Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. (2014)
- Diabetes/Metabolism Research and Reviews
Lee HS, Burkhardt BR, McLeod W, Smith S, Eberhard C, Lynch K, Hadley D, Rewers M, Simell O, She JX, Hagopian B, Lernmark A, Akolkar B, Ziegler AG, Krischer JP; TEDDY study group.